Assess whether management can run this without the founder (29dcc9)
August 31, 2026 · SmartSolo
Situation
Buy-side QoE lead in a health-system acquiring a specialty practice has one working extract — regulatory-approval critical-path calendar — after a QoE that cannot tie revenue to bank cash. If regulatory-approval critical-path calendar cannot support management can run this, the honest M&A Due Diligence output is hold.
Decision
Buy-side QoE lead in a health-system acquiring a specialty practice must choose Proceed / Reprice / Walk / Hold using regulatory-approval critical-path calendar after a QoE that cannot tie revenue to bank cash.
Hypotheses to test
- Authorize Proceed now; regulatory-approval critical-path calendar already has the discriminator after a QoE that cannot tie revenue to bank cash.
- Keep Reprice in force until regulatory-approval critical-path calendar is completed after a QoE that cannot tie revenue to bank cash for buy-side QoE lead.
- Treat regulatory-approval critical-path calendar as Walk because both readings appear after a QoE that cannot tie revenue to bank cash.
- Refuse a M&A Due Diligence close: buy-side QoE lead does not have the page management can run this turns on in regulatory-approval critical-path calendar.
Analysis required
- Name the document buy-side QoE lead still needs before signing.
- Test whether a QoE that cannot tie revenue to bank cash is a diligence gap, a price chip, or a walk-away.
- Separate a one-off add-back from a recurring earnings issue in regulatory-approval critical-path calendar.
- For this M&A Due Diligence Legal, IP, and Regulatory file, read regulatory-approval critical-path calendar against a QoE that cannot tie revenue to bank cash and write the one fact that would move management can run this for buy-side QoE lead.
Recommendation
Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Legal, IP, and Regulatory packet (regulatory-approval critical-path calendar after a QoE that cannot tie revenue to bank cash). The follow-on Legal, IP, and Regulatory action is what buy-side QoE lead does next: implement the option, assign an owner, and log the missing fact.
Command returns
Explore more
More M&A Due Diligence prompts
- Assess whether earnout definitions will cause a post-close fight (ef7b24)
- Assess whether integration costs were sandbagged in the CIM (047d78)
- Assess whether IP is owned or merely licensed (3c102e)
- Assess whether regulatory approval is a timing risk or a deal risk (04e2e8)
- Assess whether integration costs were sandbagged in the CIM (bc1b2b)
Explore related decision areas
- Assess whether bonus triggers were gamed by cutoff (a0554c)Forensic Accounting
- Assess whether cyber controls claimed are actually in force (9aef87)Insurance Underwriting
- Assess whether cyber controls claimed are actually in force (2b7bec)Insurance Underwriting
See governed multi-model AI on your own prompt
Compare GPT-5, Claude, and Gemini side by side, with human review and a decision record built in.

